[HTML][HTML] Azathioprine therapy and TPMT and NUDT15 genotype

L Dean - Medical Genetics Summaries [Internet], 2020 - ncbi.nlm.nih.gov
Azathioprine (brand names Imuran, Azasan) is an immunosuppressant that belongs to the
drug class of thiopurines. It is used with other drugs to prevent kidney transplant rejection …

A systematic review of polygenic models for predicting drug outcomes

A Siemens, SJ Anderson, SR Rassekh… - Journal of Personalized …, 2022 - mdpi.com
Polygenic models have emerged as promising prediction tools for the prediction of complex
traits. Currently, the majority of polygenic models are developed in the context of predicting …

A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine …

M Cordova-Delgado, ML Bravo, E Cumsille, CN Hill… - BMC cancer, 2021 - Springer
Background Fluoropyrimidine plus platinum chemotherapy remains the standard first line
treatment for gastric cancer (GC). Guidelines exist for the clinical interpretation of four DPYD …

[HTML][HTML] Mercaptopurine therapy and TPMT and NUDT15 genotype

L Dean, M Kane - 2020 - europepmc.org
Mercaptopurine (brand names Purinethol, Purixan) is an immunosuppressant and anti-
neoplastic agent that belongs to the drug class of thiopurines. It is used with other drugs to …

Pharmacogenetics of inflammatory bowel disease

BJC van den Bosch, MJH Coenen - Pharmacogenomics, 2021 - Taylor & Francis
Patients with inflammatory bowel disease (IBD) show large variability in disease course, and
also treatment response. The variability in treatment response has led to many initiatives in …

Precision medicine for rheumatologists: lessons from the pharmacogenomics of azathioprine

LL Daniel, AL Dickson, CP Chung - Clinical rheumatology, 2021 - Springer
Precision medicine aims to personalize treatment for both effectiveness and safety. As a
critical component of this emerging initiative, pharmacogenomics seeks to guide drug …

[HTML][HTML] Thioguanine therapy and TPMT and NUDT15 genotype

L Dean - Medical Genetics Summaries [Internet], 2020 - ncbi.nlm.nih.gov
Thioguanine (brand name Tabloid) is used to treat acute nonlymphocytic leukemias, such as
acute myeloid leukemia (AML). Thioguanine is an analogue of the nucleic acid guanine and …

[HTML][HTML] Association Between Genetically Predicted Expression of TPMT and Azathioprine Adverse Events

A Davis, AL Dickson, LL Daniel, P Nepal… - Research …, 2023 - ncbi.nlm.nih.gov
Polymorphisms thiopurine-S-methyltransferase (TPMT) and nudix hydrolase 15 (NUDT15)
can increase the risk of azathioprine myelotoxicity, but little is known about other genetic …

The development of dose-adjusted pharmacogenetic prediction models in pediatric oncology

A Siemens - 2022 - open.library.ubc.ca
Anthracyclines and cisplatin are two widely-used chemotherapeutic agents in the treatment
of pediatric cancers. However, their use is limited by severe life-threatening and life-altering …

[PDF][PDF] Miguel Cordova-Delgado1, 2, 3, María Loreto Bravo3, Elisa Cumsille2, Charlotte N. Hill2, 4, Matías Muñoz-Medel3, Mauricio P. Pinto3, Ignacio N. Retamal5 …

M Garrido, LA Quiñones, GI Owen - 2021 - bmccancer.biomedcentral.com
Background: Fluoropyrimidine plus platinum chemotherapy remains the standard first line
treatment for gastric cancer (GC). Guidelines exist for the clinical interpretation of four DPYD …